-
-
Call more information
660-596-2224 -
AUTHORS: Garg, Heena MD et al Anesthesia & Analgesia 139(6):p 1144-1155, December 2024. BACKGROUND: A systematic review and meta-analysis was conducted to compare phenylephrine boluses versus prophylactic infusion in parturients undergoing cesarean delivery under spinal or combined spinal-epidural anesthesia on feto-maternal outcomes. METHODS: Medline, Embase, Cochrane, and US Clinical registry databases were searched. Studies comparing phenylephrine […]
Read MoreAuthors: Ashie Kapoor, M.D. et al Anesthesiology November 2024. Introduction Extracorporeal cardiopulmonary resuscitation (ECPR) for refractory in-hospital cardiac arrest has been associated with improved survival compared with conventional cardiopulmonary resuscitation (CPR). Perioperative patients represent a unique of the inpatient population. This study aims to describe and analyze the characteristics and outcomes of patients who received […]
Read MoreWe are forming a new group in Riverdale GA which is 10 minutes from the Atlanta Airport. We are seeking a dedicated anesthesiologist and CRNA to join our new anesthesia group. Our care team will consist of 4 full-time CRNAs and 2 anesthesiologists managing 4 operating rooms. Position Highlights: Bread and Butter cases no heads, […]
Read MoreWe are seeking a dedicated anesthesiologist to join our all-anesthesiologist group. Our team will consist of 4 full-time providers and 1 for vacation relief, managing 3 operating rooms. Position Highlights: Zero call for 3 weeks, followed by 1 week of call without daytime work only call after 7 PM therefore you may not work the […]
Read MoreAuthors: Laura K. Schnider, M.Sc. et al Anesthesiology November 2024. Background The locus coeruleus (LC) noradrenergic system may provide a potential new target for pharmacological insomnia treatment, particularly in patients suffering from elevated distress. The selective α2 noradrenergic agonist dexmedetomidine attenuates LC activity in sub-anesthetic doses, yet no adequate non-parental delivery systems of dexmedetomidine are currently […]
Read MoreAuthor: Patsy Newitt Becker’s ASC Review The American Society of Anesthesiologists and the American Association of Nurse Anesthesiology have both issued responses to Anthem Blue Cross Blue Shield’s recent reversal of a controversial anesthesia policy. The policy update would have introduced a new reimbursement structure based on CMS physician work time values. Claims exceeding these predetermined time […]
Read MoreASA Monitor December 2024, Vol. 88, 28–29. Shockwave Medical expands U.S. Peripheral IVL portfolio with enhanced catheter Shockwave Medical, Inc., part of Johnson & Johnson MedTech, announced the full U.S. launch of the Shockwave E8 Peripheral IVL Catheter, following clearance by the FDA. The Shockwave E8 catheter is designed to optimize the treatment of patients with calcified femoro-popliteal […]
Read MoreAuthors: Rory V. Mather, MS et al Anesthesiology November 2024. Background With estimated global post-operative mortality rates at 1-4% leading to approximately 3-12 million deaths per year, an urgent need exists for reliable measures of perioperative risk. Existing approaches suffer from poor performance, place a high burden on clinicians to gather data, or do not […]
Read MoreAuthor: Muhammad B. Rafique, MD, FASA ASA Monitor December 2024, Vol. 88, 13–14. He was a brilliant anesthesiologist at the top of his career when, one day, he could not intubate a neonate and was worried. The next day, his family thought he did not look well and took him to the emergency room. A CT […]
Read MoreAuthors: Rita Saynhalath, M.D et al Anesthesiology December 2024, Vol. 141, 1075–1085. Background The Trial Remifentanil DEXmedetomidine (TREX) trial aimed to determine whether, in children less than 2 yr old, low-dose sevoflurane/dexmedetomidine/remifentanil anesthesia is superior to standard-dose sevoflurane anesthesia in terms of global cognitive function at 3 yr of age. The aim of the current secondary […]
Read More